WAM
Warberg Asset Management’s Protagenic Therapeutics, Inc. Warrant PTIXW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-170,242
| Closed | -$1.28K | – | 193 |
|
|
2025
Q1 | $1.28K | Hold |
170,242
| – | – | ﹤0.01% | 163 |
|
|
2024
Q4 | $1.04K | Sell |
170,242
-6,954
| -4% | -$42 | ﹤0.01% | 163 |
|
|
2024
Q3 | $2.11K | Hold |
177,196
| – | – | ﹤0.01% | 155 |
|
|
2024
Q2 | $1.45K | Hold |
177,196
| – | – | ﹤0.01% | 175 |
|
|
2024
Q1 | $5.74K | Hold |
177,196
| – | – | ﹤0.01% | 151 |
|
|
2023
Q4 | $1.56K | Hold |
177,196
| – | – | ﹤0.01% | 171 |
|
|
2023
Q3 | $5.32K | Hold |
177,196
| – | – | ﹤0.01% | 170 |
|
|
2023
Q2 | $5.94K | Hold |
177,196
| – | – | ﹤0.01% | 158 |
|
|
2023
Q1 | $4.29K | Hold |
177,196
| – | – | ﹤0.01% | 190 |
|
|
2022
Q4 | $7.27K | Sell |
177,196
-108,301
| -38% | -$4.44K | ﹤0.01% | 187 |
|
|
2022
Q3 | $12K | Sell |
285,497
-42,726
| -13% | -$1.8K | ﹤0.01% | 194 |
|
|
2022
Q2 | $49K | Sell |
328,223
-33,843
| -9% | -$5.05K | 0.01% | 118 |
|
|
2022
Q1 | $78K | Buy |
362,066
+180,532
| +99% | +$38.9K | 0.01% | 117 |
|
|
2021
Q4 | $69K | Sell |
181,534
-183,257
| -50% | -$69.7K | 0.01% | 115 |
|
|
2021
Q3 | $143K | Sell |
364,791
-999
| -0.3% | -$392 | 0.02% | 92 |
|
|
2021
Q2 | $260K | Buy |
+365,790
| New | +$260K | 0.05% | 78 |
|